HCPCS code M0249 — Adm tocilizu covid-19 1st.
Status: Active.
Effective Jun 24, 2021.
Source: CMS HCPCS Level II.
M0249
ActiveAdm tocilizu covid-19 1st
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
Category:
Medical Services
Section:
M-codes: Medical Services
Effective:
Jun 24, 2021
Code type:
alphanumeric
OPPS Status:
S
— Significant procedure — not subject to multiple procedure reduction
OPPS APC:
1506
MUE — Medically Unlikely Edits
Maximum units of M0249 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 1 |
| Practitioner Services | 1 |
Source: CMS Medicare NCCI Medically Unlikely Edits
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2021-Q2Adm tocilizu covid-19 1st